Follow
Hoda Anwar
Hoda Anwar
Verified email at kasralainy.edu.eg
Title
Cited by
Cited by
Year
Absolute number of new lesions on 18F-FDG PET/CT is more predictive of clinical response than SUV changes in metastatic melanoma patients receiving ipilimumab
H Anwar, C Sachpekidis, J Winkler, A Kopp-Schneider, U Haberkorn, ...
European journal of nuclear medicine and molecular imaging 45, 376-383, 2018
1412018
Characterization of arthralgia induced by PD-1 antibody treatment in patients with metastasized cutaneous malignancies
K Buder-Bakhaya, K Benesova, C Schulz, H Anwar, ...
Cancer Immunology, Immunotherapy 67, 175-182, 2018
882018
The role of interim 18F-FDG PET/CT in prediction of response to ipilimumab treatment in metastatic melanoma
C Sachpekidis, H Anwar, J Winkler, A Kopp-Schneider, L Larribere, ...
European Journal of Nuclear Medicine and Molecular Imaging 45, 1289-1296, 2018
832018
Longitudinal studies of the 18F-FDG kinetics after ipilimumab treatment in metastatic melanoma patients based on dynamic FDG PET/CT
C Sachpekidis, H Anwar, JK Winkler, A Kopp-Schneider, L Larribere, ...
Cancer Immunology, Immunotherapy 67, 1261-1270, 2018
212018
The value of different 18F-FDG PET/CT baseline parameters in risk stratification of stage I surgical NSCLC patients
H Anwar, TJ Vogl, MA Abougabal, F Grünwald, P Kleine, S Elrefaie, ...
Annals of Nuclear Medicine 32, 687-694, 2018
112018
Quantitative analysis of 18F-NaF dynamic PET/CT cannot differentiate malignant from benign lesions in multiple myeloma
C Sachpekidis, J Hillengass, H Goldschmidt, H Anwar, U Haberkorn, ...
American Journal of Nuclear Medicine and Molecular Imaging 7 (4), 148, 2017
62017
Fluorine-18-FDG PET/CT in a patient with angiomyolipoma: response to mammalian target of rapamycin inhibitor therapy
M Schwarzbach, MD Strauss
Hellenic Journal of Nuclear Medicine 20 (2), 169-171, 2017
52017
Absolute number of new lesions in 18F-FDG PET/CT is more predictive of clinical outcome than SUV changes in metastatic melanoma patients receiving ipilimumab
H Anwar, C Sachpekidis, J Winkler, A Kopp-Schneider, U Haberkorn, ...
EANM'17, 2017
12017
Delineating Metabolic Tumor Volume In NSCLC: Which Thresholding Method Should Be Used?
H Anwar, T Vogl, M Abougabal, F Grünwald, P Kleine, S Elrefaie, ...
EANM'19, 2019
2019
Die prognostische Rolle von F-18-FDG PET/CT Untersuchungen für die Evaluation der Ipilimumab Therapie bei Patienten mit metastasiertem Melanom
H Anwar
2019
Prognostic Role of F-18-FDG PET, CT Studies for Treatment Evaluation of Ipilimumab in Metastatic Melanoma Patients
H Anwar
Ruprecht-Karls-Universität zu Heidelberg, 2018
2018
Value of EORTC criteria in treatment monitoring of melanoma patients receiving ipilimumab
H Anwar, C Sachpekidis, J Winkler, J Hassel, U Haberkorn, ...
Journal of Nuclear Medicine 58 (supplement 1), 1089-1089, 2017
2017
Prognostic value of post-treatment 18F-FDG PET/CT studies in melanoma patients receiving ipilimumab
H Anwar, C Sachpekidis, J Winkler, J Hassel, U Haberkorn, ...
Journal of Nuclear Medicine 58 (supplement 1), 1088-1088, 2017
2017
Characterization of Arthralgia under PD-1 Inhibitor Therapy
K Buder-Bakhaya, K Benesova, H Anwar, T Weber, ...
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT 15, 87-88, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–14